Cargando…

Human tauopathy-derived tau strains determine the substrates recruited for templated amplification

Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Specifically, three-repeat tau and four-repeat tau in Alzheimer’s disease, three-repeat tau in Pick’s disease (PiD) and four-repeat tau in progressive supranuclear palsy (PSP) and corticobasal degenerati...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarutani, Airi, Miyata, Haruka, Nonaka, Takashi, Hasegawa, Kazuko, Yoshida, Mari, Saito, Yuko, Murayama, Shigeo, Robinson, Andrew C, Mann, David M A, Tomita, Taisuke, Hasegawa, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418341/
https://www.ncbi.nlm.nih.gov/pubmed/33693528
http://dx.doi.org/10.1093/brain/awab091
_version_ 1783748559282110464
author Tarutani, Airi
Miyata, Haruka
Nonaka, Takashi
Hasegawa, Kazuko
Yoshida, Mari
Saito, Yuko
Murayama, Shigeo
Robinson, Andrew C
Mann, David M A
Tomita, Taisuke
Hasegawa, Masato
author_facet Tarutani, Airi
Miyata, Haruka
Nonaka, Takashi
Hasegawa, Kazuko
Yoshida, Mari
Saito, Yuko
Murayama, Shigeo
Robinson, Andrew C
Mann, David M A
Tomita, Taisuke
Hasegawa, Masato
author_sort Tarutani, Airi
collection PubMed
description Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Specifically, three-repeat tau and four-repeat tau in Alzheimer’s disease, three-repeat tau in Pick’s disease (PiD) and four-repeat tau in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) form amyloid-like fibrous structures that accumulate in neurons and/or glial cells. Amplification and cell-to-cell transmission of abnormal tau based on the prion hypothesis are believed to explain the onset and progression of tauopathies. Recent studies support not only the self-propagation of abnormal tau, but also the presence of conformationally distinct tau aggregates, namely tau strains. Cryogenic electron microscopy analyses of patient-derived tau filaments have revealed disease-specific ordered tau structures. However, it remains unclear whether the ultrastructural and biochemical properties of tau strains are inherited during the amplification of abnormal tau in the brain. In this study, we investigated template-dependent amplification of tau aggregates using a cellular model of seeded aggregation. Tau strains extracted from human tauopathies caused strain-dependent accumulation of insoluble filamentous tau in SH-SY5Y cells. The seeding activity towards full-length four-repeat tau substrate was highest in CBD-tau seeds, followed by PSP-tau and Alzheimer’s disease (AD)-tau seeds, while AD-tau seeds showed higher seeding activity than PiD-tau seeds towards three-repeat tau substrate. Abnormal tau amplified in cells inherited the ultrastructural and biochemical properties of the original seeds. These results strongly suggest that the structural differences of patient-derived tau strains underlie the diversity of tauopathies, and that seeded aggregation and filament formation mimicking the pathogenesis of sporadic tauopathy can be reproduced in cultured cells. Our results indicate that the disease-specific conformation of tau aggregates determines the tau isoform substrate that is recruited for templated amplification, and also influences the prion-like seeding activity.
format Online
Article
Text
id pubmed-8418341
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-84183412021-09-09 Human tauopathy-derived tau strains determine the substrates recruited for templated amplification Tarutani, Airi Miyata, Haruka Nonaka, Takashi Hasegawa, Kazuko Yoshida, Mari Saito, Yuko Murayama, Shigeo Robinson, Andrew C Mann, David M A Tomita, Taisuke Hasegawa, Masato Brain Original Articles Tauopathies are a subset of neurodegenerative diseases characterized by abnormal tau inclusions. Specifically, three-repeat tau and four-repeat tau in Alzheimer’s disease, three-repeat tau in Pick’s disease (PiD) and four-repeat tau in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) form amyloid-like fibrous structures that accumulate in neurons and/or glial cells. Amplification and cell-to-cell transmission of abnormal tau based on the prion hypothesis are believed to explain the onset and progression of tauopathies. Recent studies support not only the self-propagation of abnormal tau, but also the presence of conformationally distinct tau aggregates, namely tau strains. Cryogenic electron microscopy analyses of patient-derived tau filaments have revealed disease-specific ordered tau structures. However, it remains unclear whether the ultrastructural and biochemical properties of tau strains are inherited during the amplification of abnormal tau in the brain. In this study, we investigated template-dependent amplification of tau aggregates using a cellular model of seeded aggregation. Tau strains extracted from human tauopathies caused strain-dependent accumulation of insoluble filamentous tau in SH-SY5Y cells. The seeding activity towards full-length four-repeat tau substrate was highest in CBD-tau seeds, followed by PSP-tau and Alzheimer’s disease (AD)-tau seeds, while AD-tau seeds showed higher seeding activity than PiD-tau seeds towards three-repeat tau substrate. Abnormal tau amplified in cells inherited the ultrastructural and biochemical properties of the original seeds. These results strongly suggest that the structural differences of patient-derived tau strains underlie the diversity of tauopathies, and that seeded aggregation and filament formation mimicking the pathogenesis of sporadic tauopathy can be reproduced in cultured cells. Our results indicate that the disease-specific conformation of tau aggregates determines the tau isoform substrate that is recruited for templated amplification, and also influences the prion-like seeding activity. Oxford University Press 2021-03-09 /pmc/articles/PMC8418341/ /pubmed/33693528 http://dx.doi.org/10.1093/brain/awab091 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Tarutani, Airi
Miyata, Haruka
Nonaka, Takashi
Hasegawa, Kazuko
Yoshida, Mari
Saito, Yuko
Murayama, Shigeo
Robinson, Andrew C
Mann, David M A
Tomita, Taisuke
Hasegawa, Masato
Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
title Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
title_full Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
title_fullStr Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
title_full_unstemmed Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
title_short Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
title_sort human tauopathy-derived tau strains determine the substrates recruited for templated amplification
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418341/
https://www.ncbi.nlm.nih.gov/pubmed/33693528
http://dx.doi.org/10.1093/brain/awab091
work_keys_str_mv AT tarutaniairi humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification
AT miyataharuka humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification
AT nonakatakashi humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification
AT hasegawakazuko humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification
AT yoshidamari humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification
AT saitoyuko humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification
AT murayamashigeo humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification
AT robinsonandrewc humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification
AT manndavidma humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification
AT tomitataisuke humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification
AT hasegawamasato humantauopathyderivedtaustrainsdeterminethesubstratesrecruitedfortemplatedamplification